Company / PP&E (Net)
DaVita PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.8B
FY2025
5-year range
$2.8B / $3.5B
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
#19 of 132
Health Care
What the data says
DaVita's pp&e (net) of $2.8B is higher than 86% of companies in the Health Care sector (FY2025). PP&E (Net) has declined for 5 consecutive years, from $3.5B in FY2020 to $2.8B in FY2025.
Based on SEC 10-K filings.
$2.8B in FY2025 with a 5-year CAGR of -4.4%. Top quartile in the Health Care sector.
Declined from $3.1B to $2.8B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- -4.4%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 132This company $2.8B Sector average $1.4B
▼
+96.0% above sector average
Key checks
Key Insights
- DaVita's pp&e (net) has declined for 5 consecutive years.
- 5-year CAGR of -4.4%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 4.4% year-over-year.
- Ranks #19 out of 132 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8B | -4.4% |
| FY2024 | $2.9B | -4.3% |
| FY2023 | $3.1B | -5.6% |
| FY2022 | $3.3B | -6.4% |
| FY2021 | $3.5B | -1.2% |
| FY2020 | $3.5B | +1.4% |
| FY2019 | $3.5B | +2.3% |
| FY2018 | $3.4B | +7.8% |
| FY2017 | $3.1B | +10.0% |
| FY2016 | $2.9B | +2.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026